Posted by Michael Wonder on 10 Apr 2026
Foundayo (orforglipron), Lilly's new oral GLP-1 pill for weight loss, now available in the US
9 April 2026 - Foundayo, the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions, starts at $25 per month with commercial coverage and $149/month with self-pay.
Eli Lilly and Company today announced that Foundayo (orforglipron) is now available to adults with obesity or overweight with weight-related medical problems following the US FDA approval on 1 April 2026.
